Cosette Pharmaceuticals is a US based, diversified pharmaceutical company with a proven topicals and dermatology portfolio and a growing branded pharmaceuticals business. We are fully integrated, with a deep focus on internal R&D, high quality manufacturing standards and commercial sales excellence. We continue to diversify and expand through strategic partnerships, acquisitions and internal R&D. Our highly experienced leadership team are busy writing the next, most ambitious chapter of our story. Building on a 100+ year heritage, their shared vision of innovation will leverage the expertise of more than 350+ team members, and infrastructure to create remarkable new opportunities for the patients and physicians we serve every day. Innovating every day.™ For complaints and medical inquiries, Contact: Email: drugsafety@cosettepharma.com Phone: 1 800-922-1038
View Top Employees from Cosette Pharmaceuticals, Inc.Website | http://www.cosettepharma.com |
Revenue | $4 million |
Employees | 187 (166 on RocketReach) |
Founded | 2019 |
Address | 200 Crossing Blvd Fl 4, Bridgewater, New Jersey 08807, US |
Phone | (800) 922-1038 |
Fax | (908) 222-1067 |
Technologies |
JavaScript,
HTML,
PHP
+22 more
(view full list)
|
Industry | Pharmaceutical Manufacturing, Manufacturing General, Pharmaceuticals, Manufacturing |
Keywords | Pharmaceutical Products, Branded Pharmaceuticals, Manufacturing, Prescription Drug, Skin Care, Over The Counter, Generic Drugs |
SIC | SIC Code 283 Companies, SIC Code 28 Companies |
NAICS | NAICS Code 3254 Companies, NAICS Code 32541 Companies, NAICS Code 32 Companies, NAICS Code 325 Companies |
Looking for a particular Cosette Pharmaceuticals, Inc. employee's phone or email?
The Cosette Pharmaceuticals, Inc. annual revenue was $4 million in 2024.
166 people are employed at Cosette Pharmaceuticals, Inc..
Cosette Pharmaceuticals, Inc. is based in Bridgewater, New Jersey.
The NAICS codes for Cosette Pharmaceuticals, Inc. are [3254, 32541, 32, 325].
The SIC codes for Cosette Pharmaceuticals, Inc. are [283, 28].